All Virology articles – Page 3
-
NewsCOVID-19 reanimates latent viruses in cells – particularly in ME patients
Researchers have found that COVID-19 reactivates viruses that had become latent in cells following previous infections, particularly in people with chronic fatigue syndrome, also known as ME/CFS.
-
NewsSARS-CoV-2 alters functioning of RNA in infected cells
Researchers have shown that infection by SARS-CoV-2, the virus that causes COVID-19, changes the functioning of host cell RNA.
-
OpinionEngineering viruses to make the world a more dangerous place
Virologists should think thrice before embarking on gain of function experiments
-
NewsCoffee compound could offer protection from catching COVID-19
Researchers have shown that a compound found in coffee could help to protect against infection by Covid-19.
-
NewsMonkeypox mutations cause virus to spread rapidly and dodge vaccines
Researchers at the University of Missouri have identified the specific mutations in the monkeypox virus that contribute to its continued infectiousness.
-
NewsNew monkeypox study increases fear of potential escalation in central Africa
A new study of monkeypox infections in a remote area of the Democratic Republic of the Congo (DRC) shows transmission rates rising closer to the point where outbreaks are likely to be larger and more frequent.
-
NewsCOVID-19 virus increases risk of other infections by disrupting normal mix of gut bacteria
Infection with Covid-19 can reduce the number of bacterial species in a patient’s gut, with the lesser diversity creating space for dangerous microbes to thrive, a new study has found.
-
NewsExperimental monoclonal antibodies take the fight to Epstein-Barr virus
Researchers have discovered a panel of investigational monoclonal antibodies (mAbs) targeting different sites of the Epstein-Barr virus (EBV) blocked infection when tested in human cells in a laboratory setting.
-
NewsResearchers find SARS-CoV-2 Omicron BA.2 subvariant less severe than earlier variants
team led by investigators at Massachusetts General Hospital (MGH) has determined that the SARS-CoV-2 Omicron BA.2 subvariant is less severe than the previous Delta variant and less severe to an even greater extent than the original Omicron variant.
-
NewsmRNA vaccines significantly reduce severity of Delta, Omicron COVID-19 infections
People who have received several doses of an mRNA COVID-19 vaccine are more likely to have milder illnesses if infected with Delta or Omicron variants than those who are unvaccinated.
-
NewsResearchers identify compounds that inhibit monkeypox virus replication
Researchers from Boston University Chobanian & Avedisian School of Medicine have developed a novel compound that soon could be used to protect against all tested poxviruses that cause human disease, including monkeypox.
-
NewsAdvanced cryo-electron microscope reveals how poliovirus rearranges human cells
Researchers at Umeå University, Sweden, have shone a light on how poliovirus behaves when it takes over an infected cell and tricks the cell into producing new virus particles.
-
NewsClinical trial launched to evaluate antiviral drug for monkeypox
A clinical trial to evaluate the antiviral drug tecovirimat, also known as TPOXX, in adults and children with monkeypox has begun in the Democratic Republic of the Congo (DRC).
-
FeaturesBrown Institution
The new United States Embassy was previously the site of a microbiological institution.
-
FeaturesMitigate or suppress—coming to grips with the COVID-19 pandemic
In the absence of an efficient vaccine, the control of the COVID-19 pandemic currently relies on non-pharmaceutical interventions.
-
FeaturesThe danger in the bat: a novel tool to detect sarbecoviruses
Infections with different coronaviruses can lead to various symptoms and their virulence is in no way deducible from their genomes.
-
FeaturesViral discovery gone mainstream
There are more viruses in the ocean than there are estimated stars in the universe.
- Previous Page
- Page1
- Page2
- Page3
- Next Page
